Medline Inc. Overview
Pro stress-test →Medline is recognized as the largest provider of medical-surgical ("med-surg") products and supply chain solutions based on total net sales, serving all points of care including hospitals, surgery centers, physician offices, and post-acute facilities. The company completed a record-setting $6.26B IPO in December 2025, allocating proceeds primarily to reduce leveraged buyout debt from 2021.
Strategic Profile
Pro stress-test →Through two primary segments—Medline Brand and Supply Chain Solutions—the company offers approximately 335,000 med-surg products including surgical and procedural kits, gloves and protective apparel, urological and incontinence care products, wound care solutions, and consumable laboratory and diagnostic items. Medline operates around 26 manufacturing facilities across North America, allowing the company to control product specifications, make quick adjustments, and scale new products faster, resulting in lower costs and reduced supplier dependency.
Competitive Landscape
Pro stress-test →Medline is the recognized largest provider of medical-surgical products and supply chain solutions by total net sales. Key competitors include McKesson Healthcare (medical distribution), Cardinal Health (healthcare supplies), Henry Schein (dental and medical supplies), Baxter International (medical products), and Stryker Corporation (surgical equipment). Medline's vertical integration with 26 North American manufacturing facilities and 335,000-product portfolio provides significant competitive moat.
Industry Context
Medline Inc. operates in Healthcare Products & Distribution / Medical Supplies Manufacturing.
Key facts
Founded: 1966 · Headquarters: Northfield, Illinois · Employees: 43,000+ · Revenue: $20.6B · Market cap: $57.9B